PMA

P860008: ARZCO TRANSESOPHAGEAL CARDIAC STIMULATOR MODEL 7

FDA PMA · SYSTEM, ESOPHAGEAL PACING · Cardio Command

Key facts

PMA number P860008
Trade name ARZCO TRANSESOPHAGEAL CARDIAC STIMULATOR MODEL 7
Generic name SYSTEM, ESOPHAGEAL PACING
Applicant Cardio Command
Owner/operator CARDIOCOMMAND, INC.
Product code LPA
Approval date Dec 30, 1986
Docket number 87M-0009
Notice date Feb 25, 1987
Establishment registration 1927197
FEI number 1927197

At a glance

  • 10–99 Supplements
  • Jun 19, 2017 Latest supplement decision
  • No Withdrawn
  • No Summary of safety and effectiveness on file
  • 10–99 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals